{"product_id":"onsior-cat-6-mg-6-tablets-reatment-of-pain-and-inflammation-associated-with-acute-and-chronic-musculoskeletal-disorders-in-cats","title":"ONSIOR Cat 6 mg \/ 6 TABLETS \/\/ reatment of pain and inflammation associated with acute and chronic musculoskeletal disorders in cats","description":"\u003cp\u003e\u003cspan\u003eFor the treatment of pain and inflammation associated with acute and chronic musculoskeletal disorders in cats. It also helps to reduce the moderate pain and inflammation associated with orthopedic surgery in cats.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cb\u003eProducer:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eElanco\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eDescription:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eFor the treatment of pain and inflammation associated with acute and chronic musculoskeletal disorders in cats.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFor the reduction of moderate pain and inflammation associated with orthopedic surgery in cats.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eIngredients:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eRobenacoxib 6 mg\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eList of excipients: Powdered yeast, Microcrystalline cellulose, Povidone (K-30), Crospovidone, Colloidal anhydrous silicon dioxide, Magnesium stearate.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eKey benefits:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eRobenacoxib is a non-steroidal anti-inflammatory drug (NSAID) of the coxib class.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eRobenacoxib tablets reduced pain and inflammation associated with acute musculoskeletal disorders and reduced the need for emergency treatment when administered as premedication before orthopedic interventions in combination with opioids.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn two clinical studies in cats (mainly indoor) with chronic musculoskeletal disorders (CMSD), robenacoxib increased activity and improved subjective scores of activity, behavior, quality of life, temperament and well-being in cats.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eIntended for:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eCats.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eMode of administration:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eOral administration.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAdminister without food or with a small amount of food.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eForm of presentation:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eFoil of 6 tablets.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eDosage\u003c\/b\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eThe recommended dose of robenacoxib is 1 mg\/kg body weight, with a variation between 1 - 2.4 mg\/kg.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe following number of tablets will be administered once a day at the same time each day:\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cimg alt=\"Onsior 6mg for cats - Dosage according to weight\" class=\"img-editor\" src=\"https:\/\/gomagcdn.ro\/domains2\/vetplanet.ro\/files\/files\/onsior-6mg-pisica-doze-de-administrare-in-functie-de-greutate-6263.png\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003eAcute musculoskeletal disorders\u003c\/b\u003e\u003c\/em\u003e : treatment up to 6 days.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003eChronic musculoskeletal disorders\u003c\/b\u003e\u003c\/em\u003e : The duration of treatment must be determined individually. A clinical response is normally seen within 3-6 weeks. If no clinical response occurs after 6 weeks, treatment should be discontinued.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003eOrthopedic surgery\u003c\/b\u003e\u003c\/em\u003e : It will be administered as a single oral treatment before the orthopedic intervention. Premedication must be administered only in combination with butorphanol - analgesia.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe tablet\/tablets must be taken without food at least 30 minutes before the intervention.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAfter the intervention, the treatment administered once a day can be continued for a maximum of two days.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIf necessary, additional analgesic treatment with opioids is recommended.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInterchangeable use of Onsior tablets and Onsior injectable solution was tested in an animal safety study and proved to be well tolerated by cats.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn cats, Onsior injectable solution or tablets can be used interchangeably in accordance with the indications and instructions for use approved for each individual pharmaceutical form.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eTreatment should not exceed one dose (either tablet or injectable solution) per day.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePlease note that the recommended dosage is different for the 2 formulations.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003ePossible adverse effects\u003c\/b\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eMild and transient diarrhoea, loose stools or vomiting were frequently reported in clinical trials with treatment up to 6 days.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eLethargy can be observed in very rare cases.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn addition, very rarely, increased renal parameters (creatinine, BUN and SDMA) and renal failure have been reported, more commonly in elderly cats and with the concomitant use of anesthetic and sedative drugs.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIf you notice serious reactions or other effects not mentioned in the leaflet, please inform your veterinarian.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003ePrecautions:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eThe safety of the veterinary medicinal product has not been established in cats weighing less than 2.5 kg or less than 4 months of age.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe use of the product in cats with impaired cardiac, renal or hepatic function or dehydrated, hypovolaemic or hypotensive cats may involve additional risks. If use cannot be avoided, these cats require close monitoring.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUse this veterinary medicinal product under the strict supervision of the veterinarian in the case of cats at risk of gastrointestinal ulcers or if the cat has previously shown intolerance to other drugs in the NSAID group.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eDo not use in pregnant or lactating animals because the safety of robenacoxib has not been established during pregnancy and lactation or in cats used for breeding purposes.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eOnsior should not be administered together with other NSAIDs or glucocorticosteroids.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePrevious treatment with other anti-inflammatory drugs may cause additional or increased adverse effects and, consequently, there should be a period of at least 24 hours without treatment with such substances before starting treatment with Onsior.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eConcomitant treatment with drugs that act on renal flow, for example diuretics or angiotensin-converting enzyme inhibitors, should be clinically monitored.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe simultaneous administration of potentially nephrotoxic substances should be avoided because it can cause an increased risk of renal toxicity.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe simultaneous use of other active substances that have a high level of protein binding may compete with robenacoxib for binding and thus cause toxic effects.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eMethod of storage:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eStore away from moisture and direct sunlight, at temperatures up to 25°C.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eIn case of overdose:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eIn healthy young cats, 7-8 months of age, robenacoxib administered orally at high doses (4, 12, or 20 mg\/kg\/day for 6 weeks) did not cause symptoms associated with toxicity, including signs of gastrointestinal toxicity, renal or hepatic and did not produce effects on the coagulation time.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn healthy young cats, 7-8 months of age, oral administration of robenacoxib (Onsior tablets, overdose up to 5 times the maximum recommended dose, 92.4 mg, 7.2 mg, 12 mg robenacoxib\/kg body weight) for 6 months it was well tolerated.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn treated animals, a reduction in weight gain was observed. In the high-dose group, kidney weight was decreased and sporadically associated with renal tubular degeneration\/regeneration, but not correlated with evidence of renal dysfunction on clinical pathologic parameters.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInterchangeable use of Onsior tablets and Onsior injectable solution in cats aged 4 months in overdoses up to 3 times the maximum recommended dose (2.4 mg, 4.8 mg, 7.2 mg robenacoxib\/kg body weight orally and 2, 0 mg, 4.0 mg and 6.0 mg robenacoxib\/kg body weight subcutaneously) resulted in dose-dependent increases in sporadic injection site edema and inflammation minor to moderate subacute\/chronic subcutaneous tissue.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNo relevant effects on body weight, bleeding time or signs of gastrointestinal, renal or hepatic toxicity were observed.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAs with any NSAIDs, overdose can cause gastrointestinal, kidney or liver toxicity in cats prone to such conditions or who have already suffered from such conditions.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThere is no specific antidote.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSymptomatic, maintenance treatment is recommended, which should consist of the administration of agents for gastrointestinal protection and infusion with physiological serum.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eIn case of overdose, please contact your veterinarian immediately.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePer il trattamento del dolore e dell'infiammazione associati a disturbi muscoloscheletrici acuti e cronici nei gatti. Aiuta anche a ridurre il dolore moderato e l'infiammazione associati alla chirurgia ortopedica nei gatti.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cb\u003eDescrizione:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ePer il trattamento del dolore e dell'infiammazione associati a disturbi muscoloscheletrici acuti e cronici nei gatti.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePer la riduzione del dolore moderato e dell'infiammazione associati alla chirurgia ortopedica nei gatti.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eIngredienti:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eRobenacoxib 6mg\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eElenco degli eccipienti: Lievito in polvere, Cellulosa microcristallina, Povidone (K-30), Crospovidone, Biossido di silicio anidro colloidale, Magnesio stearato.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eVantaggi principali:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eRobenacoxib è un farmaco antinfiammatorio non steroideo (FANS) della classe dei coxib.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eLe compresse di robenacoxib hanno ridotto il dolore e l’infiammazione associati a disturbi muscoloscheletrici acuti e hanno ridotto la necessità di trattamenti di emergenza quando somministrati come premedicazione prima di interventi ortopedici in combinazione con oppioidi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn due studi clinici condotti su gatti (principalmente indoor) affetti da disturbi muscoloscheletrici cronici (CMSD), robenacoxib ha aumentato l'attività e migliorato i punteggi soggettivi di attività, comportamento, qualità della vita, temperamento e benessere nei gatti.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eDestinato a:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eGatti.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eModalità di somministrazione:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eSomministrazione orale.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSomministrare senza cibo o con una piccola quantità di cibo.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eForma di presentazione:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eFoglio da 6 compresse.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eDosaggio\u003c\/b\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eLa dose raccomandata di robenacoxib è 1 mg\/kg di peso corporeo, con una variazione tra 1 e 2,4 mg\/kg.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIl seguente numero di compresse verrà somministrato una volta al giorno ogni giorno alla stessa ora:\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cimg alt=\"Onsior 6mg per gatti - Dosaggio in base al peso\" class=\"img-editor\" src=\"https:\/\/gomagcdn.ro\/domains2\/vetplanet.ro\/files\/files\/onsior-6mg-pisica-doze-de-administrare-in-functie-de-greutate-6263.png\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003ePatologie muscoloscheletriche acute\u003c\/b\u003e\u003c\/em\u003e : trattamento fino a 6 giorni.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003eDisturbi muscoloscheletrici cronici\u003c\/b\u003e\u003c\/em\u003e : la durata del trattamento deve essere determinata individualmente. Una risposta clinica si osserva normalmente entro 3-6 settimane. Se non si verifica alcuna risposta clinica dopo 6 settimane, il trattamento deve essere interrotto.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cem\u003e\u003cb\u003eChirurgia ortopedica\u003c\/b\u003e\u003c\/em\u003e : verrà somministrato come trattamento orale unico prima dell'intervento ortopedico. La premedicazione deve essere somministrata solo in combinazione con butorfanolo - analgesia.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eLa compressa\/le compresse devono essere assunte senza cibo almeno 30 minuti prima dell'intervento.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eDopo l'intervento, il trattamento somministrato una volta al giorno può essere continuato per un massimo di due giorni.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSe necessario, si raccomanda un ulteriore trattamento analgesico con oppioidi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eL'uso intercambiabile delle compresse di Onsior e della soluzione iniettabile di Onsior è stato testato in uno studio sulla sicurezza degli animali e si è dimostrato ben tollerato dai gatti.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNel gatto, Onsior soluzione iniettabile o compresse possono essere utilizzate in modo intercambiabile secondo le indicazioni e le istruzioni per l'uso approvate per ogni singola forma farmaceutica.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIl trattamento non deve superare una dose (compressa o soluzione iniettabile) al giorno.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSi prega di notare che il dosaggio raccomandato è diverso per le 2 formulazioni.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003ePossibili effetti avversi\u003c\/b\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eDiarrea lieve e transitoria, feci molli o vomito sono stati frequentemente segnalati negli studi clinici con trattamento fino a 6 giorni.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn casi molto rari si può osservare letargia.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eInoltre, molto raramente sono stati segnalati aumenti dei parametri renali (creatinina, BUN e SDMA) e insufficienza renale, più comunemente nei gatti anziani e con l'uso concomitante di farmaci anestetici e sedativi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSe notate reazioni gravi o altri effetti non menzionati nel foglio illustrativo, informate il vostro veterinario.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003ePrecauzioni:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eLa sicurezza del medicinale veterinario non è stata stabilita nei gatti di peso inferiore a 2,5 kg o di età inferiore a 4 mesi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eL'uso del prodotto in gatti con funzionalità cardiaca, renale o epatica compromessa o in gatti disidratati, ipovolemici o ipotesi può comportare rischi aggiuntivi. Se l'uso non può essere evitato, questi gatti richiedono un attento monitoraggio.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUsare questo medicinale veterinario sotto lo stretto controllo del veterinario in caso di gatti a rischio di ulcera gastrointestinale o se il gatto ha precedentemente mostrato intolleranza ad altri farmaci del gruppo dei FANS.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNon usare in animali in gravidanza o in allattamento poiché la sicurezza del robenacoxib non è stata stabilita durante la gravidanza e l'allattamento o nei gatti utilizzati a fini riproduttivi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eOnsior non deve essere somministrato insieme ad altri FANS o glucocorticosteroidi.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUn precedente trattamento con altri farmaci antinfiammatori può causare ulteriori o maggiori effetti avversi e, di conseguenza, è necessario trascorrere un periodo di almeno 24 ore senza trattamento con tali sostanze prima di iniziare il trattamento con Onsior.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIl trattamento concomitante con farmaci che agiscono sul flusso renale, ad esempio diuretici o inibitori dell’enzima di conversione dell’angiotensina, deve essere monitorato clinicamente.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eLa somministrazione contemporanea di sostanze potenzialmente nefrotossiche deve essere evitata perché può causare un aumento del rischio di tossicità renale.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eL'uso simultaneo di altri principi attivi che hanno un elevato livello di legame proteico può competere con il robenacoxib per il legame e quindi causare effetti tossici.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eMetodo di conservazione:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eConservare lontano dall'umidità e dalla luce solare diretta, a temperature fino a 25°C.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003cb\u003eIn caso di sovradosaggio:\u003c\/b\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eIn gatti giovani sani, di 7-8 mesi di età, il robenacoxib somministrato per via orale ad alte dosi (4, 12 o 20 mg\/kg\/die per 6 settimane) non ha causato sintomi associati a tossicità, inclusi segni di tossicità gastrointestinale, renale o epatico e non ha prodotto effetti sul tempo di coagulazione.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIn gatti giovani sani, di 7-8 mesi di età, la somministrazione orale di robenacoxib (compresse di Onsior, sovradosaggio fino a 5 volte la dose massima raccomandata, 92,4 mg, 7,2 mg, 12 mg di robenacoxib\/kg di peso corporeo) per 6 mesi è andata bene tollerato.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNegli animali trattati è stata osservata una riduzione dell’aumento di peso. Nel gruppo ad alto dosaggio, il peso dei reni era ridotto e sporadicamente associato a degenerazione\/rigenerazione tubulare renale, ma non correlato con evidenza di disfunzione renale sui parametri clinico-patologici.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUso intercambiabile delle compresse di Onsior e della soluzione iniettabile di Onsior nei gatti di età pari o superiore a 4 mesi in caso di sovradosaggio fino a 3 volte la dose massima raccomandata (2,4 mg, 4,8 mg, 7,2 mg di robenacoxib\/kg di peso corporeo per via orale e 2,0 mg, 4,0 mg e 6,0 mg robenacoxib\/kg di peso corporeo per via sottocutanea) ha comportato aumenti dose-dipendenti di edema e infiammazione sporadici nel sito di iniezione tessuto sottocutaneo subacuto\/cronico da lieve a moderato.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNon sono stati osservati effetti rilevanti sul peso corporeo, sul tempo di sanguinamento o su segni di tossicità gastrointestinale, renale o epatica.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eCome con qualsiasi FANS, il sovradosaggio può causare tossicità gastrointestinale, renale o epatica nei gatti soggetti a tali condizioni o che hanno già sofferto di tali condizioni.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNon esiste un antidoto specifico.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSi raccomanda un trattamento sintomatico di mantenimento, che dovrebbe consistere nella somministrazione di agenti per la protezione gastrointestinale e nell'infusione di siero fisiologico.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eIn caso di sovradosaggio, contattare immediatamente il veterinario.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELANCO","offers":[{"title":"Default Title","offer_id":49594551992667,"sku":"","price":53.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0476\/3261\/3543\/files\/onsior-pisica-6-mg-folie-6-tablete-690211.webp?v=1732875622","url":"https:\/\/www.petshopluna.com\/products\/onsior-cat-6-mg-6-tablets-reatment-of-pain-and-inflammation-associated-with-acute-and-chronic-musculoskeletal-disorders-in-cats","provider":"Pet Shop Maya","version":"1.0","type":"link"}